HarmonIQ Biosciences is pioneering the world’s first wearable continuous hormone monitoring (CHM) device, offering real-time, minimally invasive tracking of hormones — a major advancement over traditional blood tests and lab-based hormone panels set to disrupt the $54 billion dollar markets of IVF/menopause.
HarmonIQ's founding team is led by Mario Sierra, a biochemist and clinical research expert with a degree from UT Austin and extensive industry background spanning medical devices, consumer wearables, and software startups.
With this expertise, HarmonIQ is set to build a breakthrough hormone monitoring platform that is poised to transform women’s health, men’s health, and endocrinology research. HarmonIQ is actively forging partnerships with leading research institutions and healthcare providers, and seeking early backing from pre-seed stage investors
Company Details
- Employees
- 3
- Founded
- 2024
- Address
- Soho House Austin
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Keywords
- Cadence Neuroscience.
Harmoniq Biosciences Questions
Harmoniq Biosciences's website is https://harmoniqbiosciences.beehiiv.com/subscribe
Harmoniq Biosciences's LinkedIn profile is https://www.linkedin.com/company/harmoniq-biosciences
Harmoniq Biosciences has
3 employees.
View email and phone details for 3
employees at Harmoniq Biosciences.
Harmoniq Biosciences's industry is
Hospitals and Health Care
Harmoniq Biosciences's top competitors are
Sync N,
Coherence Neuro,
Branch,
Prosper Xo,
Inbrain Neuroelectronics,
Cadence Neuroscience,
Persperity Health,
Fidu,
Sersense, Inc.,
Paradromics.
Harmoniq Biosciences's categories are Hospitals and Health Care
Harmoniq Biosciences's founding year is 2024
